We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Meta Platforms (Facebook)
META
$1.51T
| $18.4M | 0.82% |
95,486
-85,957
| -47% | -$15.7M |
|
27
Mondelez International
MDLZ
$77.7B
| $16.2M | 0.73% |
301,077
+196,816
| +189% | +$10.2M |
|
28
Union Pacific
UNP
$183B
| $16.2M | 0.72% |
95,687
-36,206
| -27% | -$6.2M |
|
29
Philip Morris
PM
$301B
| $16.2M | 0.72% |
205,675
+110,341
| +116% | +$9.12M |
|
30
Zimmer Biomet
ZBH
$17.7B
| $15.4M | 0.69% |
+135,025
| New | +$15.8M |
|
31
Fastenal
FAST
$54B
| $14.9M | 0.67% |
+914,224
| New | +$15.1M |
|
32
Align Technology
ALGN
$12B
| $14.5M | 0.65% |
+53,033
| New | +$16M |
|
33
Capital One
COF
$124B
| $14.1M | 0.63% |
155,235
+146,144
| +1,608% | +$13.1M |
|
34
Norfolk Southern
NSC
$78.8B
| $13.3M | 0.6% |
66,902
+21,359
| +47% | +$4.24M |
|
35
RTX Corp
RTX
$287B
| $13.3M | 0.6% |
+162,350
| New | +$13.6M |
|
36
Alphabet (Google) Class A
GOOGL
$3.91T
| $13M | 0.58% |
240,100
-16,180
| -6% | -$937K |
|
|
WBA
37
DELISTED
Walgreens Boots Alliance
WBA
| $12.9M | 0.58% |
+236,715
| New | +$12.6M |
|
38
NRG Energy
NRG
$29.8B
| $12.8M | 0.57% |
364,374
+157,017
| +76% | +$5.92M |
|
39
Campbell Soup
CPB
$6.51B
| $12.3M | 0.55% |
306,176
+197,396
| +181% | +$7.75M |
|
40
Mastercard
MA
$477B
| $11.9M | 0.53% |
45,124
+31,962
| +243% | +$8M |
|
41
Elevance Health
ELV
$81.9B
| $11.7M | 0.53% |
41,622
-4,227
| -9% | -$1.15M |
|
|
SCHW
42
Charles Schwab
SCHW
$177B
| $11.7M | 0.52% |
289,935
-77,194
| -21% | -$3.36M |
|
43
CSX Corp
CSX
$98.6B
| $11.5M | 0.52% |
+447,372
| New | +$11.5M |
|
44
PACCAR
PCAR
$69.6B
| $11M | 0.49% |
229,248
+214,278
| +1,431% | +$9.96M |
|
45
Lincoln National
LNC
$7.91B
| $10.8M | 0.48% |
167,803
+47,068
| +39% | +$3.01M |
|
46
Gilead Sciences
GILD
$161B
| $10.7M | 0.48% |
157,718
-1,747
| -1% | -$115K |
|
47
FirstEnergy
FE
$28.9B
| $10.6M | 0.48% |
248,462
-228,549
| -48% | -$9.6M |
|
48
JPMorgan Chase
JPM
$939B
| $10.4M | 0.46% |
+92,662
| New | +$10.2M |
|
49
Centene
CNC
$31.3B
| $10.3M | 0.46% |
+195,817
| New | +$10.6M |
|
50
Regeneron Pharmaceuticals
REGN
$68.8B
| $10.1M | 0.45% |
32,238
+31,519
| +4,384% | +$10.5M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.